# Baim Institute for Clinical Research

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/baim-institute-for-clinical-research/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 82 |
| Citations | 399,886 |
| City | Boston |
| Country | US |
| Description | Baim Institute for Clinical Research is a research organisation in Boston, US. OpenAlex records 1,970 works and 399,886 citations for it. 268 researchers list it as their most recent affiliation. |
| Homepage | https://www.baiminstitute.org/ |
| OpenAlex ID | https://openalex.org/I4210111520 |
| Region | Massachusetts |
| Researchers | 268 |
| ROR ID | https://ror.org/01va8fr66 |
| Type | nonprofit |
| Works | 1,970 |

## University papers

Showing 12 of 18.

- [Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/prasugrel-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [Standardized Bleeding Definitions for Cardiovascular Clinical Trials](https://scholariq.org/papers/standardized-bleeding-definitions-for-cardiovascular-clinical-trials/)
- [Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban](https://scholariq.org/papers/comparison-of-early-invasive-and-conservative-strategies-in-patients-with/)
- [Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation](https://scholariq.org/papers/addition-of-clopidogrel-to-aspirin-and-fibrinolytic-therapy-for-myocardial/)
- [Rivaroxaban in Patients with a Recent Acute Coronary Syndrome](https://scholariq.org/papers/rivaroxaban-in-patients-with-a-recent-acute-coronary-syndrome/)
- [TIMI Frame Count](https://scholariq.org/papers/timi-frame-count/)
- [Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial](https://scholariq.org/papers/prasugrel-compared-with-clopidogrel-in-patients-undergoing-percutaneous-coronary/)
- [Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy](https://scholariq.org/papers/prognostic-value-of-quantitative-contrast-enhanced-cardiovascular-magnetic/)
- [Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention](https://scholariq.org/papers/defining-high-bleeding-risk-in-patients-undergoing-percutaneous-coronary-2/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)
- [2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials](https://scholariq.org/papers/2017-cardiovascular-and-stroke-endpoint-definitions-for-clinical-trials/)
- [Intravenous Platelet Blockade with Cangrelor during PCI](https://scholariq.org/papers/intravenous-platelet-blockade-with-cangrelor-during-pci/)

## University top topics

Showing 8 of 25.

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.